The hemodynamic and atrial electrophysiologic consequences of chronic left atrial volume overload in a controllable canine model
- PMID: 30336917
- PMCID: PMC6935371
- DOI: 10.1016/j.jtcvs.2018.05.078
The hemodynamic and atrial electrophysiologic consequences of chronic left atrial volume overload in a controllable canine model
Abstract
Objective: The purpose of this study was to determine the effects of chronic left atrial volume overload on atrial anatomy, hemodynamics, and electrophysiology using a titratable left ventriculoatrial shunt in a canine model.
Methods: Canines (n = 16) underwent implantation of a shunt between the left ventricle and the left atrium. Sham animals (n = 8) underwent a median sternotomy without a shunt. Atrial activation times and effective refractory periods were determined using 250-bipolar epicardial electrodes. Biatrial pressures, systemic pressures, left atrial and left ventricle diameters and volumes, atrial fibrillation inducibility, and durations were recorded at the initial and at 6-month terminal study.
Results: Baseline shunt fraction was 46% ± 8%. The left atrial pressure increased from 9.7 ± 3.5 mm Hg to 13.8 ± 4 mm Hg (P < .001). At the terminal study, the left atrial diameter increased from a baseline of 2.9 ± 0.05 cm to 4.1 ± 0.6 cm (P < .001) and left ventricular ejection fraction decreased from 64% ± 1.5% to 54% ± 2.7% (P < .001). Induced atrial fibrillation duration (median, range) was 95 seconds (0-7200) compared with 0 seconds (0-40) in the sham group (P = .02). The total activation time was longer in the shunt group compared with the sham group (72 ± 11 ms vs 62 ± 3 ms, P = .003). The right atrial and not left atrial effective refractory periods were shorter in the shunt compared with the sham group (right atrial effective refractory period: 156 ± 11 ms vs 141 ± 11 ms, P = .005; left atrial effective refractory period: 142 ± 23 ms vs 133 ± 11 ms, P = .35).
Conclusions: This canine model of mitral regurgitation reproduced the mechanical and electrical remodeling seen in clinical mitral regurgitation. Left atrial size increased, with a corresponding decrease in left ventricle systolic function, and an increased atrial activation times, lower effective refractory periods, and increased atrial fibrillation inducibility. This model provides a means to understand the remodeling by which mitral regurgitation causes atrial fibrillation.
Keywords: atrial fibrillation; mitral regurgitation.
Copyright © 2018. Published by Elsevier Inc.
Conflict of interest statement
Conflict of Interest Statement
R.J.D. is a speaker for AtriCure, Inc, LivaNova, Inc, CryoLife, Inc, and Edwards Lifesciences, Inc, and a consultant for Medtronic, Inc. He has received research funding and educational grants from AtriCure, Inc, and Edwards Lifesciences, Inc. All other authors have nothing to disclose with regard to commercial support.
Figures
![FIGURE 1.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0002.gif)
![FIGURE 2.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0003.gif)
![FIGURE 3.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0004.gif)
![FIGURE 4.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0005.gif)
![FIGURE 5.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0006.gif)
![FIGURE 6.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0007.gif)
![FIGURE 7.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0008.gif)
![VIDEO 1.](https://webcf.waybackmachine.org/web/20220710001137im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6935371/bin/nihms-1063170-f0009.gif)
Comment in
-
The new age of atrial fibrillation: Back to the lab.J Thorac Cardiovasc Surg. 2018 Nov;156(5):1880. doi: 10.1016/j.jtcvs.2018.06.045. Epub 2018 Jul 31. J Thorac Cardiovasc Surg. 2018. PMID: 30075961 No abstract available.
-
Modify, simplify, apply: Do we need preclinical models for surgical innovation?J Thorac Cardiovasc Surg. 2018 Nov;156(5):1869-1870. doi: 10.1016/j.jtcvs.2018.07.024. Epub 2018 Jul 20. J Thorac Cardiovasc Surg. 2018. PMID: 30098807 No abstract available.
Similar articles
-
The Electrophysiologic Effects of Acute Mitral Regurgitation in a Canine Model.Ann Thorac Surg. 2017 Apr;103(4):1277-1284. doi: 10.1016/j.athoracsur.2016.08.011. Epub 2016 Oct 15. Ann Thorac Surg. 2017. PMID: 27756468 Free PMC article.
-
Effects of atrial fibrosis induced by mitral regurgitation on atrial electrophysiology and susceptibility to atrial fibrillation in pigs.Cardiovasc Pathol. 2019 May-Jun;40:32-40. doi: 10.1016/j.carpath.2019.01.006. Epub 2019 Jan 28. Cardiovasc Pathol. 2019. PMID: 30836303
-
Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation.Circulation. 2003 May 27;107(20):2615-22. doi: 10.1161/01.CIR.0000066915.15187.51. Epub 2003 May 5. Circulation. 2003. PMID: 12732604 Free PMC article.
-
Subtypes of Atrial Functional Mitral Regurgitation: Imaging Insights Into Their Mechanisms and Therapeutic Implications.JACC Cardiovasc Imaging. 2020 Mar;13(3):820-835. doi: 10.1016/j.jcmg.2019.01.040. Epub 2019 Aug 14. JACC Cardiovasc Imaging. 2020. PMID: 31422123 Review.
-
Mechanistic insights into atrial functional mitral regurgitation: Far more complicated than just left atrial remodeling.Echocardiography. 2019 Jan;36(1):164-169. doi: 10.1111/echo.14249. Echocardiography. 2019. PMID: 30620100 Review.
Cited by 6 articles
-
The Arrhythmic Substrate for Atrial Fibrillation in Patients with Mitral Regurgitation.J Atr Fibrillation. 2020 Aug 31;13(2):2304. doi: 10.4022/jafib.2304. eCollection 2020 Aug. J Atr Fibrillation. 2020. PMID: 34950292 Free PMC article.
-
Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.PLoS One. 2021 Jul 15;16(7):e0254887. doi: 10.1371/journal.pone.0254887. eCollection 2021. PLoS One. 2021. PMID: 34265016 Free PMC article.
-
Association between functional mitral regurgitation and recurrence of paroxysmal atrial fibrillation following catheter ablation: a prospective cohort study.J Int Med Res. 2021 May;49(5):3000605211014375. doi: 10.1177/03000605211014375. J Int Med Res. 2021. PMID: 33983087 Free PMC article.
-
hsa-miR-4443 inhibits myocardial fibroblast proliferation by targeting THBS1 to regulate TGF-β1/α-SMA/collagen signaling in atrial fibrillation.Braz J Med Biol Res. 2021 Mar 3;54(4):e10692. doi: 10.1590/1414-431X202010692. eCollection 2021. Braz J Med Biol Res. 2021. PMID: 33681892 Free PMC article.
-
The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation.Cardiovasc Res. 2022 Jan 29;118(2):440-460. doi: 10.1093/cvr/cvab035. Cardiovasc Res. 2022. PMID: 33576384 Free PMC article. Review.
Publication types
MeSH terms
Grant support
LinkOut - more resources
Full Text Sources
Medical